Randomised controlled, crossover trial to evaluate the effects of ambulatory oxygen on health status in patients with fibrotic lung disease

Dina Visca (Mantova, Italy), Dina Visca, Sharon Fleming, Ashi Firouzi, Morag Farquhar, Nicholas Hopkinson, Charlotte Hogben, Winston Banya, Paul Cullinan, Angelo De Lauretis, Maria Kokosi, John Tayu Lee, Rosemarie Lyne, Sarah Agnew, Apollo Kwok, Surinder Birring, Alfredo Chetta, Anne Marie Russell, Peter Saunders, Toby Maher, Athol Wells, Lisa Spencer, Elisabetta Renzoni

Source: International Congress 2016 – Clinical aspects of ILD
Session: Clinical aspects of ILD
Session type: Thematic Poster
Number: 797
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Dina Visca (Mantova, Italy), Dina Visca, Sharon Fleming, Ashi Firouzi, Morag Farquhar, Nicholas Hopkinson, Charlotte Hogben, Winston Banya, Paul Cullinan, Angelo De Lauretis, Maria Kokosi, John Tayu Lee, Rosemarie Lyne, Sarah Agnew, Apollo Kwok, Surinder Birring, Alfredo Chetta, Anne Marie Russell, Peter Saunders, Toby Maher, Athol Wells, Lisa Spencer, Elisabetta Renzoni. Randomised controlled, crossover trial to evaluate the effects of ambulatory oxygen on health status in patients with fibrotic lung disease. Eur Respir J 2016; 48: Suppl. 60, 797

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Short-burst oxygen therapy for COPD patients: a 6-month randomised, controlled study
Source: Eur Respir J 2006; 27: 697-704
Year: 2006



Effective delivery of ambulatory oxygen in interstitial lung disease- a crossover trial
Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration
Year: 2019


Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – A prospective, randomized, controlled trial
Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2016


An auto-titrating intelligent oxygen therapy (iO2T) system in COPD patients: A randomised cross-over trial
Source: International Congress 2015 – Tele-rehabilitation in chronic lung diseases
Year: 2015



AmbOx trial: does ambulatory oxygen improve quality of life in patients with fibrotic interstitial lung disease?
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017

A randomised double-blind placebo-controlled trial of the effect of inhaled heparin on lung function, hyperinflation and exercise capacity in patients with COPD
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016

Effects of supplemental oxygen vs. room air in COPD patients: A randomized placebo-controlled trial
Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases
Year: 2015

Effects of a 3-week pulmonary rehabilitation program in patients with idiopathic pulmonary fibrosis – A randomized, controlled trial
Source: International Congress 2016 – Novel approaches for pulmonary rehabilitation in chronic lung diseases
Year: 2016


Maintenance of exercise capacity following pulmonary rehabilitation in COPD: randomised controlled trial
Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions
Year: 2009



Effect of hyperoxia on exercise performance in COPD: Randomized trial
Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease
Year: 2016


Exercise training improves exercise capacity and quality of life in people with dust-related pleural and interstitial respiratory diseases: A randomised controlled trial
Source: Annual Congress 2011 - Exercise training: new populations, new techniques
Year: 2011

Effect of high-flow oxygen therapy on exercise tolerance in idiopathic pulmonary fibrosis: a randomized crossover trial.
Source: Virtual Congress 2021 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2021



Maintaining benefits following pulmonary rehabilitation: a randomised controlled trial
Source: Eur Respir J 2010; 35: 571-577
Year: 2010



Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with precapillary pulmonary hypertension and sleep disturbed breathing. Randomized, double-blind, cross-over trial
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial
Source: Breathe, 15 (2) 140; 10.1183/20734735.0002-2019
Year: 2019



The influence of lung volume reduction surgery on exercise in patients with COPD
Source: Eur Respir J 2004; 23: 269-274
Year: 2004



Effects of additional manual therapy over inspiratory muscle training in patients with chronic obstructive pulmonary disease: A randomized controlled trial
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015


Heliox and alveolar oxygenation in patients with chronic obstructive pulmonary disease: a multicentre, randomised, crossover study
Source: Eur Respir J 2004; 24: Suppl. 48, 243s
Year: 2004

Randomized controlled trial of abituzumab in systemic sclerosis-associated interstitial lung disease
Source: International Congress 2017 – New ideas for the management of chronic lung diseases
Year: 2017




Acute effects of supplemental oxygen therapy using different nasal cannulas on walking capacity in patients with idiopathic pulmonary fibrosis: a randomised crossover trial
Source: ERJ Open Res, 6 (3) 00197-2020; 10.1183/23120541.00197-2020
Year: 2020